Larimar Therapeutics LRMR

$ 4.0 0.5%

Quarterly report 2024-Q3
added 10-30-2024

Larimar Therapeutics Cash and Cash Equivalents 2011-2024 | LRMR

Annual Cash and Cash Equivalents Larimar Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
26.7 M	26.8 M	70.1 M	68.1 M	27.2 M	49.3 M	40.8 M	32.4 M	35.6 M	58.1 M	35.5 M	9.94 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
70.1 M	9.94 M	40.1 M

Quarterly Cash and Cash Equivalents Larimar Therapeutics

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
35.1 M	32.3 M	110 M	26.7 M	38.7 M	94.3 M	112 M	26.8 M	86 M	19.7 M	62.6 M	70.1 M	71.5 M	70.6 M	62.2 M	68.1 M	68.1 M	68.1 M	68.1 M	1.01 M	1.01 M	1.01 M	27.2 M	49.3 M	49.3 M	49.3 M	49.3 M	40.8 M	40.8 M	40.8 M	40.8 M	32.4 M	32.4 M	32.4 M	32.4 M	35.6 M	35.6 M	35.6 M	35.6 M	58.1 M	58.1 M	58.1 M	58.1 M	35.5 M	35.5 M	35.5 M	-	9.94 M	-	-	-	1.47 M	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
112 M	1.01 M	45.9 M